Paul Runyan, VP sales & marketing, Accumold explores the complexities of micro moulding for medical devices, highlighting the intricate processes, precision requirements, challenges with biocompatible materials, and quality standards.
Macmillan Cancer Support is investing £350,100 in Lucida Medical’s new AI platform, Pi, with the aim of improving the speed and accuracy of prostate cancer tests.
Sidley Austin’s Josefine Sommer, partner specialising in food, drug and medical device regulation, and Michelle Gandolfo, managing associate, outlines how new European battery regulations may impact medical device manufacturers in the UK.
Jonathan Ripley, IVD and MD consulting services director at IMed Consultancy discusses the role of IVDs, regulatory perspectives for their adoption and increased market access.
The rapid growth of the global plastics recycling market hides a sector undergoing dramatic change. Recent innovations all along the plastics recycling value chain are transforming the very foundations of the industry while unlocking new found value.
Mark Brady, programme leader – spine at Invibio, discusses how people are living and staying active longer and expecting more quality of life than ever before and how this has been made possible, in part, by advancements in material sciences.
Paul Runyan, VP sales & marketing, Accumold delves into the intricacies of material selection, highlighting how critical properties such as strength, flexibility, and thermal resistance shape the functionality of micromoulded components.
Hologic’s new Genius Digital Diagnostics System with the Genius Cervical AI algorithm has received clearance from the U.S. Food and Drug Administration (FDA).
Alan Messenger, sales director, and Matt Jones, account manager at Optimal Industrial Automation, look at the importance of undertaking comprehensive site surveys before the upgrade of industrial automation systems.
Lucida Medical, the University of Cambridge and Hampshire Hospitals NHS Foundation Trust have been awarded funding by Innovate UK and the Office for Life Sciences to extend the Pi software platform to multiple clinical indications.
